Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form
Open Access
- 1 February 1998
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1369 (1) , 85-93
- https://doi.org/10.1016/s0005-2736(97)00185-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inorganic and organic phosphate measurements in the nanomolar rangePublished by Elsevier ,2004
- Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisersEuropean Journal Of Cancer, 1996
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- The catalytic cycle of P‐glycoproteinFEBS Letters, 1995
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxinBiochemical and Biophysical Research Communications, 1992
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- VerapamilDrugs, 1989
- Identification of P-glycoprotein in renal brush border membranesBiochemical and Biophysical Research Communications, 1989